baber/WOPTO huggingface dataset:
Patent AU-4959485-A (AU)
Title: Controlled release nifedipine preparation
Inventor: VITTORIO GIUDICE
IPC: A61K9/50
Filed: 1985-09-04
Abstract: Process for preparation of a solid administration form for oral use based on nifedipine with controlled release of the active substance, characterized by the fact that a mixture of nifedipine crystals having a specific surface area between 0.1 and 0.4 m<2>/g is prepared, said mixture of crystals is blended with an equal amount by weight of auxiliary vehicle substances, and the resulting mixture so obtained is applied on spheroids of inert substances, by means of suitable binders, in coating pans.
Patent AU-5156690-A (AU)
Title: A power plant with combustion of a fuel in a fluidized bed
Inventor: JONSSON ARNE
IPC: F23C10/16
Filed: 1990-02-08
Abstract: PCT No. PCT/SE90/00084 Sec. 371 Date Oct. 10, 1991 Sec. 102(e) Date Oct. 10, 1991 PCT Filed Feb. 8, 1990 PCT Pub. No. WO90/09550 PCT Pub. Date Aug. 23, 1990.The invention relates to a power plant with combustion of a fuel at a pressure exceeding the atmospheric pressure in a fluidized bed (18) of particulate material, a so-called PFBC power plant. A combustor (12) is enclosed within a pressure vessel (10) and surrounded by compressed combustion air. Ash chambers (44) in the lower part of the combustor (12) are enclosed in one or more spaces (50) with walls (52, 53) which are suitably designed as plane, water-cooled panel walls. The ash chambers (44) are designed with uncooled walls (62). Pressure equalizing openings (64) are provided in the ash chamber walls (62), which openings equalize any pressure differences which may arise between the ash chambers (44) and the surrounding space (50). The walls (52, 53) which form the space surrounding the ash chambers absorb the pressure difference between the ash chambers (44) and the space (32) between the combustor (12) and the pressure vessel (10).
Patent AU-5217600-A (AU)
Title: Foam-controlling process
Inventor: INGHELBRECHT KRISTIEN
IPC: D21H21/12
Filed: 2000-05-26
Abstract: Provided is a method for controlling foam formation, which method comprises contacting a substance with a foam-controlling agent comprising one or more of the following ester compounds (a)-(c):   (a) an ester formed from a saturated or unsaturated linear or branched aliphatic alcohol having from 1-18 carbon atoms, which alcohol may comprise one or more hydroxy groups, and a saturated or unsaturated linear or branched aliphatic monocarboxylic acid having from 6-24 carbon atoms, which carboxylic acid may be unsubstituted or substituted with one or more hydroxy groups; (b) an ester formed by esterifying at least one of the hydroxy groups of a saturated or unsaturated linear or branched aliphatic polyol having from 2-6 carbon atoms, with a saturated or unsaturated linear or branched aliphatic monocarboxylic acid having from 6-24 carbon atoms, which carboxylic acid may be unsubstituted or substituted with one or more hydroxy groups, or by esterifying at least one of the hydroxy groups of the polyol with an oligomer formed from condensation of the monocarboxylic acid, wherein the polyol may be partially or fully esterified; and (c) an ester formed by esterifying at least one of the hydroxy groups of a polyethyleneglycol having a molecular weight of up to 600 and/or a polypropyleneglycol having a molecular weight of up to 600, with a saturated or unsaturated linear or branched aliphatic monocarboxylic acid having from 6-24 carbon atoms, which carboxylic acid may be unsubstituted or substituted with one or more hydroxy groups, or by esterifying at least one of the hydroxy groups of the polyethyleneglycol and/or polypropyleneglycol with an oligomer formed from condensation of the monocarboxylic acid.
Patent AU-5242393-A (AU)
Title: Vibratory tumbling apparatus
Inventor: MUSSCHOOT ALBERT
IPC: B07B1/42
Filed: 1993-12-15
Abstract: A vibratory material handling apparatus (10) is provided for mixing of materials, cleaning, blending and/or shake out of castings or the like. The apparatus comprises a container (12) having a material supporting surface (14) disposed along a generally horizontal longitudinal axis (16). The container has a material input end and a material discharge end axially spaced therefrom and it is resiliently mounted relative to a mounting surface. The apparatus also includes a vibration generator (34) for producing a force to cause material within the container to be directed in a path of tumbling movement generally in a direction from the material input end toward the material discharge end of the container. With this arrangement, a tumbling assist mechanism (40) is provided for applying a force to the material in addition to the force produced by the vibration generator (34) to facilitate tumbling of the material as it moves along the path of tumbling movement. <IMAGE>
Patent AU-5244399-A (AU)
Title: Thymosin beta4 promotes wound repair
Inventor: KLEINMAN HYNDA K
IPC: A61K38/08
Filed: 1999-07-29
Abstract: The present invention relates to methods for promoting tissue repair, angiogenesis and cell migration. The method of the invention utilizes thymosin β4 (Tβ4) peptide to promote tissue repair, angiogenesis and cell migration. The invention further relates to modulating Tβ4 activity in tissues.
Patent AU-5252796-A (AU)
Title: Methods and apparatus for controlled placement of a polymer composition into a web
Inventor: CALDWELL JAMES MICHAEL
IPC: D21H19/32
Filed: 1996-03-15
Abstract: The present invention relates to methods for the controlled placement of a curable, shear thinnable polymer composition into a porous web. The controlled placement is performed by applying tension to the porous web. The polymer composition is applied onto a surface of the web. The composition is shear thinned sufficiently to reduce its viscosity and selectively place it into the tensioned web to encapsulate at least some of the structural elements of the web, leaving most of the interstitial spaces of the porous web open. The invention also relates to methods for selectively placing the polymer composition in a substantially continuous region extending through the web so that the polymer composition fills the interstitial spaces and adheres adjacent structural elements in the region. In the areas in the web above and below the filled region, at least some of the structural elements are encapsulated and most of the interstitial spaces are open. The invention also relates to methods for the controlled placement of a polymer composition into a tensioned porous substrate having a matrix of open cells by applying a localized shear force to selectively distribute a curable, shear thinnable polymer composition within the substrate, at least partially individually lining the cell walls of at least some of the cells, and leaving most of the cells open.
Patent AU-5292093-A (AU)
Title: Synthesis of n-substituted oligomers
Inventor: ZUCKERMANN RONALD N
IPC: A61K48/00
Filed: 1993-09-24
Abstract: Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: <CHEM> In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two "sub-monomers" directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound  alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.
Patent AU-5309894-A (AU)
Title: Slot machine
Inventor: TAKEMOTO TAKATOSHI
IPC: G07D/
Filed: 1994-01-11
Abstract: In a slot machine mounted thereon with a drum, a game medium insertion switch, a game medium insertion count counter, a start handle and a drum stopping switch, the slot machine is further provided with a count display portion capable of displaying the number of inserted game media and count-down, and a game end switch. <IMAGE>
Patent AU-5532399-A (AU)
Title: Apparatus for preparing sterilizing water and process for sterilizing water
Inventor: KIM HEE JUNG
IPC: B01D61/50
Filed: 1999-09-03
Abstract: The present invention provides an apparatus for preparing sterilizing water, which comprises an electrolyzer wherein an anode chamber ( 10 ) and a cathode chamber ( 20 ) partitioned by an ion exchange membrane ( 40 ) form a unit cell (A), being alternately arranged and successively equipped with close relation; water inlets ( 61, 62 ) and water outlets ( 71, 72 ) are provided on the end plate ( 60, 70 ) at both ends of the electrolyzer; said anode chamber ( 10 ) and cathode chamber ( 20 ) having circulative openings at the vicinity of each edge at both sides centered from anode plate ( 11 ) and cathode plate ( 21 ), of which two circulative openings of diagonal direction among them have plural passages of fan-shape, in order for water introduced through the openings to pass through the passages to rapidly go through each electrode; and a gap-control gasket ( 30 ) and a gasket for preventing leakage of electrolyte ( 31 ) having plural horizontal members are provided at the center to form an anode reaction chamber ( 13 ) and a cathode reaction chamber ( 23 ).
Patent AU-5710396-A (AU)
Title: Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
Inventor: KERCOEO JANEZ
IPC: A61K9/22
Filed: 1996-05-17
Abstract: PCT No. PCT/SI96/00012 Sec. 371 Date Nov. 12, 1997 Sec. 102(e) Date Nov. 12, 1997 PCT Filed May 17, 1996 PCT Pub. No. WO96/36318 PCT Pub. Date Nov. 21, 1996Described is a novel three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient stabilized with polymers for a single daily peroral application, which is especially suitable for active ingredients existing in amorphous form or in one or more polymorphous forms, which exhibit poor solubility in crystal form depending on the polymorphous form, particle size and the specific surface area of the active ingredient. The active ingredient can be used in its amorphous or any polymorphous form, which in the process of the preparation of the three-phase pharmaceutical form according to the invention is converted into the amorphous form. The three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient for a single daily peroral application contains a core consisting of a first and a second phase and a coating representing the third phase. In the first phase the three-phase pharmaceutical form contains an amorphous active ingredient, the water-soluble polymer polyvinylpyrrolidone and a cellulose ether as carriers of the amorphous active ingredient and simultaneously as inhibitors of its crystallization, a surfactant that improves the solubility of the active ingredient and promotes the absorption of the amorphous active ingredient from gastrointestinal tract, in the second phase it contains a cellulose ether and a mixture of mono-, di- and triglycerides as sustained release agents and the third phase is represented by a poorly soluble or gastro-resistant film coating, which in the first few hours after the application controls the release of the active ingredient and can consist of an ester of hydroxypropylmethylcellulose with phthalic anhydride or of a copolymerizate based on methacrylic acid and ethyl acrylate. Described is also a process for the preparation of this pharmaceutical form.
Patent AU-5746590-A (AU)
Title: Lubricating oil compositions and concentrates
Inventor: ROBY STEPHEN H
IPC: C10N10/16
Filed: 1990-05-17
Abstract: A lubricating oil composition is described which is useful in internal combustion engines and which exhibit improved oxidation and wear performance. More particularly, lubricating oil compositions are described which comprise (A) a major amount of oil of lubricating viscosity; (B) at least about 1.0 % by weight of at least one carboxylic derivative composition produced by reacting (B-1) at least one substituted succinic acylating agent with (B-2) at least one amine compound characterized by the presence within its structure of at least one HN< group wherein said substituted succinic acylating agents consist of substituent groups and succinic groups wherein the substituent groups are derived from polyalkene, said polyalkene being characterized by an Mn value of 1300 to about 5000 and an Mw/Mn value of about 1.5 to about 4.5, said acylating agents being characterized by the presence within their structure of an average of at least 1.3 succinic groups for each equivalent weight of substituent groups; and (c) at least one manganese compound in an amount sufficient to provide from 1 to about 500 ppm of manganese as metal, provided that the manganese compound is not a neutral manganese dihydrocarbyl phosphorodithioate. The oil compositions also may contain other desirable additives including (D) at least one metal dihydrocarbyl phosphorodithioate ; (E) detergent effective amounts of at least one neutral or basic alkali metal salt of a sulfonic or carboxylic acid; and/or (F) at least one carboxylic ester derivative is defined herein. In one embodiment, the oil compositions of the present invention contain the above additives and other additives described in the specification in an amount sufficient to enable the oil to meet all the performance requirements of the API Service Classification identified as "SG".
Patent AU-5832690-A (AU)
Title: Method of preparing vaccines against rna viruses
Inventor: SKINNER GORDON ROBERT BRUCE
IPC: A61K39/12
Filed: 1990-06-12
Abstract: A vaccine against a RNA virus, which may be a picorna virus, an orthomyxovirus or a retrovirus, is prepared by infecting host cells with the virus, incubating the infected cells for a time and at a temperature which is insufficient to result in lysis of the cells, separating the nuclei of the cells intact from their cytoplasmic fraction, and stabilizing viral antigenic proteins in the cytoplasmic fraction, the stabilized proteins providing the active constituent of the vaccine.
Patent AU-6064294-A (AU)
Title: Octacyclodepsipeptides having an endoparasiticidal action
IPC: C07K11/00
Filed: 1994-04-21
Abstract: The present invention relates to compounds of the general formula (I)   <IMAGE>  in which R<1>, R<2>, R<11> and R<12> are identical or different radicals of the group consisting of C1-8-alkyl, C1-8-haloalkyl, C3-6-cycloalkyl, aralkyl and aryl, and their stereoisomers, processes for their preparation and their use as endoparasiticides.
Patent AU-6159998-A (AU)
Title: Benzofurazan compounds which enhance ampa receptor activity
Inventor: ROGERS GARY A
IPC: A61P25/00
Filed: 1998-02-13
Abstract: Compounds of the general structural formula <CHEM> are shown to have AMPA receptor enhancing properties. The compounds are useful for such therapeutic purposes as facilitating the learning of behaviors dependent upon AMPA receptors, and in treating conditions, such as memory impairment, in which AMPA receptors, or synapses utilizing these receptors, are reduced in numbers or efficiency. They may also be used to enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. <IMAGE>
Patent AU-6266886-A (AU)
Title: Di-phosphonic acid inhibitors
Inventor: HWA CHIH M
IPC: C23F11/167
Filed: 1986-09-15
Abstract: Composition for inhibition of ferrous metal corrosion consisting essentially of (a) HEDPA compound and (b) HPAA compound. Optionally the composition may also include (c) an azole.
Patent AU-6282694-A (AU)
Title: Benzopyranes as potassium channel openers
Inventor: MACKENZIE ALEXANDER RODERICK
IPC: C07D405/14
Filed: 1994-03-04
Abstract: PCT No. PCT/EP94/00637 Sec. 371 Date Aug. 4, 1995 Sec. 102(e) Date Aug. 4, 1995 PCT Filed Mar. 4, 1994 PCT Pub. No. WO94/20491 PCT Pub. Date Sep. 15, 1994The present invention relates to compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein the dashed line represents an optional covalent bond; X is O, NH, S or a direct link; R3 is hydroxy when the dashed line does not represent a covalent bond and R3 is absent when the dashed line represents a covalent bond; R4 is (a), when X is O, a group of formula (i), (b), when X is O, NH or S, optionally substituted hydroxyphenyl, (c) an optionally substituted 4- to 7-membered heterocyclic ring, or (d), when X is NH, a group of formula (ii). The compounds are useful for the treatment of disease associated with the altered tone or motility of smooth muscle.    <IMAGE>  (I)   <IMAGE>  (i)   <IMAGE>  (ii)
Patent AU-6301386-A (AU)
Title: Dihydrobenzopyran derivatives
Inventor: COHEN NOAL
IPC: C07D311/66
Filed: 1986-09-22
Abstract: It has been found that the novel compounds of the formula <CHEM> wherein R<1> is hydrogen or lower alkyl, R<2> is hydrogen or halogen, R<3> is hydrogen or lower alkyl, R<4> is hydrogen or lower alkyl, R<5> is hydrogen, lower alkyl or aralkyl, X is alkylene and n is an integer from 1 to 6, the enantiomers thereof and, when R<5> is hydrogen, the salts thereof with pharmaceutically acceptable bases have antiallergic properties and can accordingly be used as medicaments for the treatment or prevention of allergic conditions. The compounds of formula I can be manufactured by reacting a compound of the formula <CHEM> with a compound of the formula <CHEM> and optionally hydrolyzing the compound thus obtained.
Patent AU-6380580-A (AU)
Title: Preparation of 5-carbamoyl-10-oxo-10,11-dihydro-5h-dibenz (b,f)azepine
Inventor: AUFDERHAAR E
IPC: C07D223/22
Filed: 1980-10-29
Abstract: The invention relates to a process for the manufacture of the known 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine of the formula III which is characterized in that, for example, 5-cyano-5H-dibenz[b,f]azepine of the formula I is nitrated to form 5-cyano-10-nitro-5H-dibenz[b,f]azepine of the formula II, this is subjected to hydrolysis, then reduction, then the reduction product contained in the reaction mixture is subjected to hydrolysis and the end product of the formula III is isolated in pure form. The process is illustrated by the following reaction scheme:   <IMAGE>    <IMAGE> +TR  <IMAGE>  The invention relates also to new intermediates produced in these reactions.
Patent AU-6670786-A (AU)
Title: Antimycotic nail varnish
Inventor: BOHN MANFRED
IPC: A61K8/00
Filed: 1986-12-18
Abstract: 1. An antimycotic nail varnish containing a) a 1-hydroxy-2-pyridone of the formula I   see diagramm : EP0226984,P8,F2   in which R**1 is a saturated hydrocarbon radical having 6-9 carbon atoms, one of the radicals R**2 and R**4 is a hydrogen atom and the other is hydrogen, methyl or ethyl and R**3 is an alkyl radical having one or two carbon atoms, in the free form or in salt form, as the antimycotic substance, b) a water-insoluble film-forming agent, c) a physiologically acceptable solvent, and if appropriate d) additives customary in cosmetics.
Patent AU-6699700-A (AU)
Title: A system and method for sending multimedia attachments to text messages in radiocommunication systems
Inventor: BENGTSSON HENRIK
IPC: H04L12/58
Filed: 2000-08-07
Abstract: Methods and systems for transmitting attachments to text messages without turning terminals into e-mail clients are described. When an attachment is to be transmitted, an address of an attachment server is appended to the text message. The text message is then forwarded to the intended recipient, e.g., via an SMS server, while the attachment is sent to the attachment server. Upon receipt of the text message, the recipient can then download the attachment from the attachment server using the address included in the text message.
Patent AU-6702698-A (AU)
Title: Synaptic activation protein compositions and method
Inventor: WORLEY PAUL F
IPC: C12N15/12
Filed: 1998-03-13
Abstract: Disclosed are nucleotide coding sequences and polypeptide sequences for synaptic activation binding proteins that are characterized by induction in the central nervous system following neuronal activity in rat hippocampus. Such proteins are identified by (i) substantial homology at the nucleotide or protein sequence level to specifically defined rat, human or mouse coding sequences or proteins, (ii) ability to bind to and affect the activity of effector proteins in the CNS, such as metabotropic glutamate receptors, (iii) binding specificity for a particular binding sequence, and (iv) presence in the sequence of a PDZ-like domain. Nucleotides and polypeptides of the invention are useful in screening and diagnostic assays.
Patent AU-6845090-A (AU)
Title: Pellets containing active principles protected against degradation in the rumen of ruminants
Inventor: ANNONIER CLAUDE
IPC: A23K1/00
Filed: 1990-12-27
Abstract: The present invention relates to novel compositions, in the form of pellets, used for the dietary and/or medicinal supplementation of ruminants, containing active substances protected against degradation in the rumen and one or more solubilisable, cross-linkable or meltable binders and, if appropriate, a separation agent and/or a filler.
Patent AU-6900696-A (AU)
Title: Method and composition for enhanced parenteral nutrition
Inventor: NAUCK MICHAEL A
IPC: A23L33/18
Filed: 1996-08-22
Abstract: A composition and method for improved administration of nutrients is described. The method includes co- or separate administration of a source of nutrients, especially carbohydrates, and insulintropic peptides and derivatives, analogs, fragments and the like. The method and composition provide high carbohydrate nutrition while avoiding hyper- and hypoglycemia and their attendant deleterious effects.
Patent AU-7043094-A (AU)
Title: L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV)and anti-HIV agents
Inventor: LIN TAI-SHUN
IPC: C07D405/04
Filed: 1994-05-23
Abstract: The present invention relates to the surprising discovery that certain dideoxynucleoside analogs which contain a dideoxy ribofuranosyl moiety having an L-configuration (as opposed to the naturally occurring D-configuration) exhibit unexpected activity against Hepatitis B virus (HBV). In particular, the compounds according to the present invention show potent inhibition of the replication of the virus in combination with very low toxicity to the host cells (i.e., animal or human tissue). Compounds according to the present invention exhibit primary utility as agents for inhibiting the growth or replication of HBV, HIV and other retroviruses, most preferably HBV. The compound 1-(2,3-dideoxy-beta-L-ribofuranosyl)-5-fluorocytosine is shown to be a potent anti-HIV agent with low toxicity to host cells.
Patent AU-7083901-A (AU)
Title: Underwater tool
Inventor: EMMETT ROBERT
IPC: E21B31/20
Filed: 2001-07-12
Abstract: To obviate the need for hydraulic lines, from the surface, external water pressure is used to compress a seal member and form a seal with a surrounding pip. Valve is opened at depth to allow water to act on a piston, moving it within a chamber so as to compress the seal member. A second valve may be opened so that water acts on the opposite end of the piston to release the seal member.